These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17323464)

  • 1. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Jansson JO; Wallenius V
    J Appl Physiol (1985); 2007 Feb; 102(2):821; author reply 825. PubMed ID: 17323464
    [No Abstract]   [Full Text] [Related]  

  • 2. Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Mooney RA
    J Appl Physiol (1985); 2007 Feb; 102(2):816-8; discussion 818-9. PubMed ID: 17284655
    [No Abstract]   [Full Text] [Related]  

  • 3. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Bülow J
    J Appl Physiol (1985); 2007 Feb; 102(2):822-3; author reply 825. PubMed ID: 17323467
    [No Abstract]   [Full Text] [Related]  

  • 4. Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis.
    Pedersen BK; Febbraio MA
    J Appl Physiol (1985); 2007 Feb; 102(2):814-6. PubMed ID: 17068210
    [No Abstract]   [Full Text] [Related]  

  • 5. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Plomgaard P; Fischer CP
    J Appl Physiol (1985); 2007 Feb; 102(2):822; author reply 825. PubMed ID: 17323466
    [No Abstract]   [Full Text] [Related]  

  • 6. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    McGuinness OP
    J Appl Physiol (1985); 2007 Feb; 102(2):823; author reply 825. PubMed ID: 17323468
    [No Abstract]   [Full Text] [Related]  

  • 7. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Shoelson SE
    J Appl Physiol (1985); 2007 Feb; 102(2):820; author reply 825. PubMed ID: 17323463
    [No Abstract]   [Full Text] [Related]  

  • 8. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Weigert C; Lehmann R; Schleicher ED
    J Appl Physiol (1985); 2007 Feb; 102(2):820-1; author reply 825. PubMed ID: 17323462
    [No Abstract]   [Full Text] [Related]  

  • 9. Point:counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Spangenburg EE
    J Appl Physiol (1985); 2007 Feb; 102(2):820; author reply 825. PubMed ID: 17284658
    [No Abstract]   [Full Text] [Related]  

  • 10. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Bastard JP; Lagathu C; Caron M; Capeau J
    J Appl Physiol (1985); 2007 Feb; 102(2):821-2; author reply 825. PubMed ID: 17323465
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis.
    Chen W; Balland E; Cowley MA
    Neuroendocrinology; 2017; 104(4):364-381. PubMed ID: 28122381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet-induced obesity and insulin resistance.
    Friedline RH; Ko HJ; Jung DY; Lee Y; Bortell R; Dagdeviren S; Patel PR; Hu X; Inashima K; Kearns C; Tsitsilianos N; Shafiq U; Shultz LD; Lee KW; Greiner DL; Kim JK
    FASEB J; 2016 Mar; 30(3):1328-38. PubMed ID: 26644351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.
    Havel PJ
    Nutr Rev; 2005 May; 63(5):133-57. PubMed ID: 15971409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, obesity, and the brain.
    Schwartz MW; Porte D
    Science; 2005 Jan; 307(5708):375-9. PubMed ID: 15662002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic control of energy and glucose metabolism.
    Sisley S; Sandoval D
    Rev Endocr Metab Disord; 2011 Sep; 12(3):219-33. PubMed ID: 21695389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of diabetes type II].
    Tatoń J; Szczeklik Z; Czech A
    Pol Tyg Lek; 1995; Suppl 1():70-7. PubMed ID: 7596915
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of interleukin-6 signalling in glucose and lipid metabolism.
    Glund S; Krook A
    Acta Physiol (Oxf); 2008 Jan; 192(1):37-48. PubMed ID: 18171428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism, treatment, and evaluation of obesity-induced insulin resistance and type 2 diabetes].
    Zhao WG; Zhu HJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):7-12. PubMed ID: 20236579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock response regulates insulin sensitivity and glucose homeostasis: pathophysiological impact and therapeutic potential.
    Kondo T; Koga S; Matsuyama R; Miyagawa K; Goto R; Kai H; Araki E
    Curr Diabetes Rev; 2011 Jul; 7(4):264-9. PubMed ID: 21682692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fats and insulin action.
    Storlien LH; Baur LA; Kriketos AD; Pan DA; Cooney GJ; Jenkins AB; Calvert GD; Campbell LV
    Diabetologia; 1996 Jun; 39(6):621-31. PubMed ID: 8781757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.